ASTRO 2022 | Is there benefit for screening all men, not just those who are high-risk, for prostate cancer?

Alex Bryant, MD, University of Michigan, Ann Arbor, MI, explains current screening guidelines for prostate cancer and discusses the pros and cons of possible earlier screening for high-risk sub-groups. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.